B-Symptom	0	7	Retinal
I-Symptom	8	13	nerve
I-Symptom	14	19	fiber
I-Symptom	20	25	layer
I-Symptom	26	32	damage
O	33	35	as
O	36	44	assessed
O	45	47	by
B-Diagnostic_tool	48	55	optical
I-Diagnostic_tool	56	65	coherence
I-Diagnostic_tool	66	76	tomography
O	77	79	in
B-Anatomy	80	84	eyes
O	85	89	with
O	90	91	a
B-Symptom	92	98	visual
I-Symptom	99	104	field
I-Symptom	105	111	defect
O	112	120	detected
O	121	123	by
B-Diagnostic_tool	124	133	frequency
I-Diagnostic_tool	134	142	doubling
I-Diagnostic_tool	143	153	technology
I-Diagnostic_tool	154	163	perimetry
O	164	167	but
O	168	171	not
O	172	174	by
B-Diagnostic_tool	175	183	standard
I-Diagnostic_tool	184	193	automated
I-Diagnostic_tool	194	203	perimetry
O	203	204	.

O	206	208	To
O	209	218	determine
O	219	226	whether
O	227	230	the
B-Symptom	231	237	visual
I-Symptom	238	243	field
I-Symptom	244	245	(
I-Symptom	245	247	VF
I-Symptom	247	248	)
I-Symptom	249	253	loss
O	254	262	detected
O	263	265	by
B-Diagnostic_tool	266	275	frequency
I-Diagnostic_tool	276	284	doubling
I-Diagnostic_tool	285	295	technology
I-Diagnostic_tool	296	305	perimetry
O	306	307	(
B-Diagnostic_tool	307	310	FDT
O	310	311	)
O	312	315	but
O	316	319	not
O	320	322	by
B-Diagnostic_tool	323	331	standard
I-Diagnostic_tool	332	341	automated
I-Diagnostic_tool	342	351	perimetry
O	352	353	(
B-Diagnostic_tool	353	356	SAP
O	356	357	)
O	358	360	is
O	361	371	associated
O	372	376	with
B-Symptom	377	384	retinal
I-Symptom	385	390	nerve
I-Symptom	391	396	fiber
I-Symptom	397	402	layer
I-Symptom	403	404	(
I-Symptom	404	408	RNFL
I-Symptom	408	409	)
I-Symptom	410	416	damage
O	417	425	measured
O	426	431	using
B-Diagnostic_tool	432	439	optical
I-Diagnostic_tool	440	449	coherence
I-Diagnostic_tool	450	460	tomography
O	461	462	(
B-Diagnostic_tool	462	465	OCT
O	465	466	)
O	466	467	.

O	468	481	Observational
O	482	486	case
O	486	487	-
O	487	494	control
O	495	500	study
O	500	501	.

O	502	508	Ninety
O	508	509	-
O	509	514	three
O	515	523	subjects
O	524	528	were
O	529	538	recruited
O	539	543	from
O	544	547	the
O	548	560	longitudinal
O	561	571	University
O	572	574	of
O	575	585	California
O	585	586	,
O	587	590	San
O	591	596	Diego
O	596	597	,
O	598	608	Diagnostic
O	609	620	Innovations
O	621	623	in
B-Disease	624	632	Glaucoma
O	633	638	Study
O	638	639	.

O	640	643	All
O	644	656	participants
O	657	660	had
O	662	663	>
O	665	667	or
O	668	669	=
O	669	670	2
O	671	679	reliable
B-Diagnostic_tool	680	683	SAP
I-Diagnostic_tool	683	684	-
I-Diagnostic_tool	684	691	Swedish
I-Diagnostic_tool	692	703	Interactive
I-Diagnostic_tool	704	711	Testing
I-Diagnostic_tool	712	721	Algorithm
O	722	725	and
B-Diagnostic_tool	726	729	FDT
I-Diagnostic_tool	730	732	24
I-Diagnostic_tool	732	733	-
I-Diagnostic_tool	733	734	2
I-Diagnostic_tool	735	740	tests
O	741	744	and
O	745	747	at
O	748	753	least
O	754	757	one
B-Diagnostic_tool	758	765	Stratus
I-Diagnostic_tool	766	769	OCT
I-Diagnostic_tool	770	774	test
O	774	775	,
O	776	779	all
O	780	789	conducted
O	790	796	within
O	797	798	a
O	799	800	6
O	800	801	-
O	801	806	month
O	807	811	time
O	812	818	window
O	818	819	.

B-Characteristic	820	827	Retinal
I-Characteristic	828	833	nerve
I-Characteristic	834	839	fiber
I-Characteristic	840	845	layer
I-Characteristic	846	855	thickness
O	856	864	measured
O	865	869	with
B-Diagnostic_tool	870	873	OCT
O	874	877	and
O	878	881	the
O	882	888	number
O	889	891	of
O	892	899	sectors
O	900	904	with
B-Diagnostic_tool	905	908	OCT
O	908	909	-
O	909	917	measured
B-Characteristic	918	922	RNFL
I-Characteristic	923	932	thickness
O	933	938	lower
O	939	943	than
O	944	947	the
O	948	950	95
O	950	951	%
O	952	962	confidence
O	963	971	interval
O	972	973	(
O	973	975	CI
O	975	976	)
O	977	979	or
O	980	982	99
O	982	983	%
O	984	986	CI
O	987	992	based
O	993	995	on
O	996	999	the
O	1000	1010	instrument
O	1010	1011	'
O	1011	1012	s
O	1013	1022	normative
O	1023	1031	database
O	1031	1032	.

O	1033	1041	Compared
O	1042	1046	with
O	1047	1052	those
O	1053	1057	with
O	1058	1064	normal
B-Diagnostic_tool	1065	1068	SAP
O	1069	1072	and
B-Diagnostic_tool	1073	1076	FDT
O	1077	1084	results
O	1084	1085	,
O	1086	1087	a
O	1088	1101	significantly
O	1102	1108	higher
O	1109	1119	proportion
O	1120	1122	of
O	1123	1131	subjects
O	1132	1136	with
O	1137	1143	normal
B-Diagnostic_tool	1144	1147	SAP
O	1148	1151	and
O	1152	1160	abnormal
B-Diagnostic_tool	1161	1164	FDT
O	1165	1172	results
O	1173	1176	had
B-Diagnostic_tool	1177	1180	OCT
O	1180	1181	-
O	1181	1189	measured
B-Characteristic	1190	1194	RNFL
I-Characteristic	1195	1204	thickness
O	1205	1212	outside
O	1213	1215	95
O	1215	1216	%
O	1217	1223	limits
O	1224	1226	in
O	1227	1230	the
O	1231	1239	inferior
O	1240	1243	and
O	1244	1252	superior
O	1253	1262	quadrants
O	1263	1264	(
O	1264	1265	P
O	1266	1267	=
O	1268	1269	0
O	1269	1270	.
O	1270	1273	048
O	1273	1274	)
O	1275	1278	and
O	1279	1286	outside
O	1287	1289	99
O	1289	1290	%
O	1291	1297	limits
O	1298	1300	in
O	1301	1304	the
O	1305	1313	inferior
O	1314	1322	quadrant
O	1323	1324	(
O	1324	1325	P
O	1326	1327	=
O	1328	1329	0
O	1329	1330	.
O	1330	1333	010
O	1333	1334	)
O	1334	1335	.

O	1336	1340	When
B-Diagnostic_tool	1341	1344	SAP
O	1345	1347	is
O	1348	1354	within
O	1355	1361	normal
O	1362	1367	range
O	1367	1368	,
O	1369	1373	some
O	1374	1382	patients
O	1383	1387	with
B-Symptom	1388	1390	VF
I-Symptom	1391	1395	loss
O	1396	1404	detected
O	1405	1407	by
B-Diagnostic_tool	1408	1411	FDT
O	1412	1416	show
O	1417	1418	a
B-Characteristic	1419	1428	decreased
I-Characteristic	1429	1433	RNFL
I-Characteristic	1434	1443	thickness
O	1443	1444	,
O	1445	1453	possibly
O	1454	1464	indicating
O	1465	1468	the
O	1469	1477	presence
O	1478	1480	of
B-Symptom	1481	1493	glaucomatous
I-Symptom	1494	1500	damage
O	1500	1501	.

O	1502	1507	These
O	1508	1515	results
O	1516	1523	support
O	1524	1527	the
O	1528	1536	validity
O	1537	1539	of
B-Diagnostic_tool	1540	1543	FDT
O	1544	1546	as
O	1547	1548	a
O	1549	1553	tool
O	1554	1556	to
O	1557	1563	detect
B-Disease	1564	1569	early
I-Disease	1570	1578	glaucoma
O	1578	1579	.
